Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Week in Review

Week in Review: A Consortium of China Drug Distributors Want to Acquire Poland's Neuca
Week in Review: Hengrui Out-Licenses Novel Anti-Inflammatory to One Bio in $1 Billion Deal
Week in Review: BeiGene and BMS Close BeiGene-Celgene PD-1 Partnership
Week in Review: Mundipharma Considers $1 Billion Sale of China Operations
Week in Review: Pyrotech Closes $97 Million Series A Round for Immunomodulator Drugs
ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China